Ureteral Obstruction Market Share, Growth And Trends Analysis By Type (Acute, Chronic) By Diagnosis (Ultrasound, Bladder Catheterization, Others) By Treatment (Surgery, Drugs) By Equipment (Devices, Consumables, Others) By End Users - Global Forecast Till 2027
Market Highlights
Ureteral obstruction or urinary tract obstruction is a condition of blockage of urine through the urinary tract, which may be complete or partial. In Ureteral obstruction the urine may refluxes backward into your kidneys. Ureteral obstruction is curable, but if not treated, can lead to loss of kidney function, sepsis and eventually death. Other severe consequences are kidney stones, and infection of the urinary tract. Mild symptoms generally in partial blockage are pain in a side, abnormal urine flow and urinating at night, acute stinging pain etc. Ureteral obstruction is caused by injuries such as a pelvic fracture, ureter, kidneys, bladder or colon cancers, kidney stones in ureter etc.
Get Sample Report at https://www.marketresearchfuture.com/sample_request/4041
The Ureteral Obstruction Market Growth for ureteral obstruction is highly fragmented due to large number of players especially in the devices segment which has put pressure on the profit margin, rise of low quality and low cost products especially catheters which reduces the market of high quality products. Also the market for ureteral obstruction is highly dependent on product development strategy such as miniaturization of ureter stents, development of coated ureter stents. The drug segment is growing at a slow pace due to saturation of the market. Considering all these factors, the market for ureteral obstruction is expected to grow at a CAGR of ~ 8.5 % during 2017-2023.
Global Ureteral obstruction market Players:
Key players profiled in the report are C. R. Bard, Inc., Boston Scientific Corporation, Cook Medical Inc., Medline Industries, Inc., Coloplast A/S, DISA Vascular, Terumo Europe NV, Medtronic, Novartis AG, Johnson and Johnson and others.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Ureteral obstruction market” Research Report – Forecast to 2023.
Segmentation:
The global ureteral obstruction market is segmented on the basis of type, diagnosis, treatment, equipment and end users. Based on type, the market has been segmented as acute and chronic. Based on the diagnosis, the market has been segmented as ultrasound, bladder catheterization, computed tomography (CT), magnetic resonance imaging (MRI), voiding cystourethrography (VCUG), pyelography, endoscopy, blood and urine tests and others. Based on the treatment, the market has been segmented as surgery (ureteral stent, nephrostomy, open laparoscopy, catheterization, robot-assisted laparoscopy, others) and drugs (antibiotics, pain killers, others). Based on the equipment, the market has been segmented as devices (catheters, stents, others) and consumables (diagnostic reagents, urinary sample collectors, others) and others. Based on the end users, the market has been segmented as hospitals and clinics, research, others.
Report Details @ https://www.marketresearchfuture.com/reports/ureteral-obstruction-market-4041
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
The making repeat of urological and kidney-related issues and the social event of innovatively progressed stents forgot and unfathomable urological techniques are the standard thoughts driving the market.
These stents are used to treat different conditions in patients with kidney stones and urinary incontinence.
These ureteral stents award the portion of additional parts without deterring the ureter.
Besides, the conventionality of prostate destructive turn of events and tumours or narrowing/scarring of the ureter requires the need for ureteral stents during or after the treatment.
The overall expanding pervasiveness of urolithiasis (kidney and ureteral stones), and urinary incontinence inferable from different factors like the rising amount of calcium in the diet, liquor admission, and negative ways of life are a central point driving the market.
This is relied upon to help the development of the ureteral stents market.
